External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Oncology ILCA 2023
Roche and Genentech at

ILCA 2023

September 07 - September 09
Amsterdam, Netherlands
ilcalive.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
Sep 14 / Roche
Watch the webcast footage from the symposium: Expanding the view: early detection and systemic treatment opportunities in HCC
Non-promotional presentation intended to facilitate transparent scientific exchange regarding developments in medical research and disease management.
Oncology Liver Cancer ILCA-2023

Sign up or login to unlock the full suite of MEDICALLY features
Sep 8 / Roche
GAAD and GALAD Algorithmic Scores Demonstrate Equivalent Clinical Performance for Detection of Early Stage Hepatocellular Carcinoma (HCC) in Prospective Multicenter Biomarker Studies
To deduce the clinical utility of AFP-L3, this study compares the clinical performance of the GALAD and GAAD algorithms for differentiating between early-stage HCC and benign CLD.
Oncology HealthTech Hepatocellular Carcinoma ILCA-2023

Sign up or login to unlock the full suite of MEDICALLY features
Sep 7 / Roche and Genentech
IMbrave050: Phase 3 study of adjuvant atezolizumab + bevacizumab versus active surveillance in patients with hepatocellular carcinoma (HCC) at high risk of disease recurrence following resection or ablation
Currently, no standard of care exists in the adjuvant setting for hepatocellular carcinoma following resection or ablation with curative intent. Here we report the results of IMbrave050, a global, open-label, Phase 3, randomized study of atezolizumab + bevacizumab vs active surveillance in patients at high risk of disease recurrence following resection or ablation with curative intent.
Oncology Hepatocellular Carcinoma ILCA-2023
05:30 PM
Duration 5mins Amsterdam, Netherlands
Expanding the view: early detection and systemic treatment opportunities in HCC (ILCA 2023: Roche-sponsored symposium)
Prof Pierce Chow, Dr Amit Singal, Dr David Pinato
Oncology | Liver Cancer

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:00 PM
Duration 10mins Plenary Room
GAAD and GALAD Algorithmic Scores Demonstrate Equivalent Clinical Performance for Detection of Early Stage Hepatocellular Carcinoma (HCC) in Prospective Multicenter Biomarker Studies
Masatoshi Kudo
Oncology - HealthTech | Hepatocellular Carcinoma

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.